91 related articles for article (PubMed ID: 2043891)
1. Detection and significance of minimal residual disease in patients with leukaemia and lymphoma.
Goldman JM; Hughes T
Bone Marrow Transplant; 1991; 7 Suppl 1():66-9. PubMed ID: 2043891
[No Abstract] [Full Text] [Related]
2. [Minimal residual disease in leukemia and lymphoma: biological significance and clinical applications].
Gavosto F; Saglìo G; Foà R
Haematologica; 1989 Oct; 74(5 Suppl):85-95. PubMed ID: 2512235
[No Abstract] [Full Text] [Related]
3. [Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases].
Jäger U; Laczika K; Scholten C; Mitterbauer M; Novak M; Lechner K
Wien Klin Wochenschr; 1996; 108(20):634-9. PubMed ID: 9005678
[TBL] [Abstract][Full Text] [Related]
4. Detection of recurrent translocations using real time PCR; assessment of the technique for diagnosis and detection of minimal residual disease.
Gabert J
Haematologica; 1999 Jun; 84 Suppl EHA-4():107-9. PubMed ID: 10907485
[No Abstract] [Full Text] [Related]
5. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
6. Detection and monitoring of minimal residual disease by quantitative real-time PCR.
Schüler F; Dölken G
Clin Chim Acta; 2006 Jan; 363(1-2):147-56. PubMed ID: 16154122
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease detection in human leukemias: biologic and clinical significance.
Saglio G
Acta Haematol Pol; 1995; 26(2 Suppl 1):19-24. PubMed ID: 7653231
[TBL] [Abstract][Full Text] [Related]
8. The detection and significance of minimal residual disease in chronic myeloid leukemia.
Radich JP
Medicina (B Aires); 2000; 60 Suppl 2():66-70. PubMed ID: 11188935
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in hematologic malignancies.
San-Miguel JF; Bartram C; Campana D; Andreeff M
Rev Invest Clin; 1994 Apr; Suppl():147-52. PubMed ID: 7886299
[No Abstract] [Full Text] [Related]
10. Detection of minimal residual disease in leukemias: a critical approach.
Baruchel A; Schaison G
Nouv Rev Fr Hematol (1978); 1990; 32(1):21-4. PubMed ID: 2190175
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
12. [Minimal residual disease. Methodologies and clinical implications].
Ortega M; Coll MD; Solé F; Caballín MR
Sangre (Barc); 1999 Aug; 44(4):283-90. PubMed ID: 10589280
[No Abstract] [Full Text] [Related]
13. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia.
Rosendahl M; Andersen MT; Ralfkiær E; Kjeldsen L; Andersen MK; Andersen CY
Fertil Steril; 2010 Nov; 94(6):2186-90. PubMed ID: 20100619
[TBL] [Abstract][Full Text] [Related]
14. The use of PCR technology for detecting minimal residual disease in patients with leukemia.
Radich JP
Rev Immunogenet; 1999; 1(2):265-78. PubMed ID: 11253952
[TBL] [Abstract][Full Text] [Related]
15. [Allogenic transplantation of bone marrow in hematologic diseases. Preparation and completion of transplantation at the Hematology Clinic in Novi Sad].
Pejin D; Popović S; Dokić M; Felle D; Stefanović N
Acta Chir Iugosl; 1990; 37 Suppl 1():11-5. PubMed ID: 2109441
[TBL] [Abstract][Full Text] [Related]
16. Is body weight a risk factor of interstitial pneumonitis after bone marrow transplantation?
Ozsahin M; Schwartz LH; Pene F; Touboul E; Schlienger M; Laugier A
Bone Marrow Transplant; 1992 Jul; 10(1):97. PubMed ID: 1515887
[No Abstract] [Full Text] [Related]
17. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
Douay L
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():195. PubMed ID: 2469509
[No Abstract] [Full Text] [Related]
18. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Barnett L; Heller G
Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
[TBL] [Abstract][Full Text] [Related]
19. [Molecular diagnosis of leukemia and lymphoma].
Iida S; Ueda R
Rinsho Byori; 1994 Apr; 42(4):364-71. PubMed ID: 8176845
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
